Related references
Note: Only part of the references are listed.Risk Factors of Coronary Artery Abnormalities and Resistance to Intravenous Immunoglobulin Plus Corticosteroid Therapy in Severe Kawasaki Disease An Analysis of Post RAISE
Koichi Miyata et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2021)
Delayed Development of Coronary Artery Aneurysm in Patients with Kawasaki Disease Who Were Clinically Responsive to Immunoglobulin
Ryohei Matsuoka et al.
JOURNAL OF PEDIATRICS (2020)
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial
Hiromichi Hamada et al.
LANCET (2019)
Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis
Audrey Dionne et al.
PEDIATRICS (2019)
Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population
Mary Beth F. Son et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study
Koichi Miyata et al.
LANCET CHILD & ADOLESCENT HEALTH (2018)
Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment
Mallory L. Downie et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores
Mary Beth F. Son et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease A Scientific Statement for Health Professionals From the American Heart Association
Brian W. McCrindle et al.
CIRCULATION (2017)
A New Z Score Curve of the Coronary Arterial Internal Diameter Using the Lambda-Mu-Sigma Method in a Pediatric Population
Tohru Kobayashi et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2016)
Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population
Kevin G. Friedman et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous γ-immunoglobulin therapy
Ming-Tai Lin et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2015)
Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial
Tohru Kobayashi et al.
LANCET (2012)
Corticosteroid Pulse Combination Therapy for Refractory Kawasaki Disease: A Randomized Trial
Shohei Ogata et al.
PEDIATRICS (2012)
Evaluation of Kawasaki Disease Risk-Scoring Systems for Intravenous Immunoglobulin Resistance
Lynn A. Sleeper et al.
JOURNAL OF PEDIATRICS (2011)
Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment
Tetsuya Sano et al.
EUROPEAN JOURNAL OF PEDIATRICS (2007)
Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease
Kimiyasu Egami et al.
JOURNAL OF PEDIATRICS (2006)
Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease
Tohru Kobayashi et al.
CIRCULATION (2006)
Share Paper
